Invasive Aspergillus Infections in a Thai Tertiary-Care Hospital during 2006-2011


From an increase in the number of immunocompromised hosts including AIDS patients, organ transplantation, solid-organ tumor, hematological malignancy, corticosteroid use, and others underlying diseases, it leads to increasing the incidence of invasive aspergillosis (IA) as one of the most prevalent opportunistic mould infections. However, the epidemiological data are still limited. Our objective is to study the epidemiology of IA, patients’ characteristics in a tertiary-care hospital, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. The retrospective study of IA as principal diagnosis in both medical and laboratory records in a tertiary-care hospital, King Chulalongkorn Memorial Hospital, from January 1, 2006 to December 31, 2011, was performed. There were 69 patients who were diagnosed as IA during 2006 till 2011. They were classified as proven (45 patients), probable (3 patients), and possible (21 patients) invasive aspergillosis following the criteria of European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG), 2008. The numbers of patients in 2006 to 2011 were 3, 11, 12, 10, 10, and 23 respectively. Male patients were 58 percent. The age range was from 8 months to 87 years old. Most of patients were from Medicine ward. Others were derived from Pediatrics, Surgery, and Ear Nose Throat wards. The most common underlying disease was diabetes mellitus type 2 in the proven group. The main predisposing factors of patients were the history of pulmonary tuberculosis and using of immunosuppressive drugs. The sites of infection were lung (62%), sinus (28%), and brain (8%). Aspergillus fumigatus (69%) and Aspergillus flavus (15%) were common species from the isolated culture. The treatment used mostly was surgery and followed by amphotericin B or voriconazole. The case fatality rate of IA was 20 percent. From the epidemiological data, we can conclude that in this past ten years there is an incessant increase in the number of IA in the immunocompromised hosts especially from Aspergillus fumigatus, which is the most prevalent species found in IA. Diabetes mellitus and history of pulmonary tuberculosis will play the important role for IA in the future. The plan for prevention and treatment should be concerned about those underlying diseases and predisposing factors.

Share and Cite:

Thammahong, A. , Thayidathara, P. , Suksawat, K. and Chindamporn, A. (2015) Invasive Aspergillus Infections in a Thai Tertiary-Care Hospital during 2006-2011. Advances in Microbiology, 5, 298-306. doi: 10.4236/aim.2015.55029.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Walsh, T.J., Anaissie, E.J., Denning, D.W., Herbrecht, R., Kontoyiannis, D.P., Marr, K.A., et al. (2008) Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases, 46, 327-360.
[2] Thai Health Indices (2001) Bangkok, Thailand: Office of the National Economic and Social Development Board.
[3] Slavin, M.A. and Chakrabarti, A. (2012) Opportunistic Fungal Infections in the Asia-Pacific Region. Medical Mycology: Official Publication of the International Society for Human and Animal Mycology, 50, 18-25.
[4] Kriengkauykiat, J., Ito, J.I. and Dadwal, S.S. (2011) Epidemiology and Treatment Approaches in Management of Invasive Fungal Infections. Clinical Epidemiology, 3, 175-191.
[5] Pfaller, M.A. and Diekema, D.J. (2010) Epidemiology of Invasive Mycoses in North America. Critical Reviews in Microbiology, 36, 1-53.
[6] Nucci, M., Queiroz-Telles, F., Tobon, A.M., Restrepo, A. and Colombo, A.L. (2010) Epidemiology of Opportunistic Fungal Infections in Latin America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 51, 561-570.
[7] Lehrnbecher, T., Frank, C., Engels, K., Kriener, S., Groll, A.H. and Schwabe, D. (2010) Trends in the Postmortem Epidemiology of Invasive Fungal Infections at a University Hospital. The Journal of Infection, 61, 259-265.
[8] Chakrabarti, A., Chatterjee, S.S. and Shivaprakash, M.R. (2008) Overview of Opportunistic Fungal Infections in India. Japanese Journal of Medical Mycology, 49, 165-172.
[9] Graf, K., Khani, S.M., Ott, E., Mattner, F., Gastmeier, P., Sohr, D., et al. (2011) Five-Year Surveillance of Invasive Aspergillosis in a University Hospital. BMC Infectious Diseases, 11, 163.
[10] Gangneux, J.P., Camus, C. and Philippe, B. (2010) Epidemiology of Invasive Aspergillosis and Risk Factors in Non Neutropaenic Patients. Revue des Maladies Respiratoires, 27, e34-e46.
[11] Latge, J.-P. and Steinbach, W.J. (2009) Aspergillus fumigatus and Aspergillosis. ASM Press, Washington DC.
[12] Maschmeyer, G., Haas, A. and Cornely, O.A. (2007) Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients. Drugs, 67, 1567-1601.
[13] Lin, S.J., Schranz, J. and Teutsch, S.M. (2001) Aspergillosis Case-Fatality Rate: Systematic Review of the Literature. Clinical Infectious Diseases, 32, 358-366.
[14] Neofytos, D., Fishman, J.A., Horn, D., Anaissie, E., Chang, C.H., Olyaei, A., et al. (2010) Epidemiology and Outcome of Invasive Fungal Infections in Solid Organ Transplant Recipients. Transplant Infectious Disease, 12, 220-229.
[15] Kontoyiannis, D.P., Marr, K.A., Park, B.J., Alexander, B.D., Anaissie, E.J., Walsh, T.J., et al. (2010) Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clinical Infectious Diseases, 50, 1091-1100.
[16] Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., et al. (2009) Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry. Clinical Infectious Diseases, 48, 265-273.
[17] Montejo, M. (2011) Epidemiology of Invasive Fungal Infection in Solid Organ Transplant. Revista iberoamericana de micologia: Organo de la Asociacion Espanola de Especialistas en Micologia, 28, 120-123.
[18] Fishman, J.A. (2007) Infection in Solid-Organ Transplant Recipients. The New England Journal of Medicine, 357, 2601-2614.
[19] Garcia-Vidal, C., Upton, A., Kirby, K.A. and Marr, K.A. (2008) Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation. Clinical Infectious Diseases, 47, 1041-1050.
[20] Morgan, J., Wannemuehler, K.A., Marr, K.A., Hadley, S., Kontoyiannis, D.P., Walsh, T.J., et al. (2005) Incidence of Invasive Aspergillosis Following Hematopoietic Stem Cell and Solid Organ Transplantation: Interim Results of a Prospective Multicenter Surveillance Program. Medical Mycology, 43, S49-S58.
[21] Kiertiburanakul, S., Thibbadee, C. and Santanirand, P. (2007) Invasive Aspergillosis in a Tertiary-Care Hospital in Thailand. Journal of the Medical Association of Thailand, 90, 895-902.
[22] Ungpakorn, R. (2005) Mycoses in Thailand: Current Concerns. Nihon Ishinkin Gakkai zasshi (Japanese Journal of Medical Mycology), 46, 81-86.
[23] Imwidthaya, P. (1994) Systemic Fungal Infections in Thailand. Journal of Medical and Veterinary Mycology: Bi-Monthly Publication of the International Society for Human and Animal Mycology, 32, 395-399.
[24] De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. (2008) Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases, 46, 1813-1821.
[25] Patterson, T.F., Kirkpatrick, W.R., White, M., Hiemenz, J.W., Wingard, J.R., Dupont, B., et al. (2007) Invasive Aspergillosis: Disease Spectrum, Treatment Practices, and Outcomes. I3 Aspergillus Study Group. Medicine (Baltimore), 79, 250-260.
[26] Quindos, G. (2011) Candidiasis, Aspergillosis and Other Invasive Mycoses in Recipients of Solid Organ Transplants. Revista iberoamericana de micologia: Organo de la Asociacion Espanola de Especialistas en Micologia, 28, 110-119.
[27] Chakrabarti, A., Chatterjee, S.S., Das, A. and Shivaprakash, M.R. (2011) Invasive Aspergillosis in Developing Countries. Medical Mycology, 49, S35-S47.
[28] Moreno-Navarrete, J.M. and Fernandez-Real, J.M. (2011) Antimicrobial-Sensing Proteins in Obesity and Type 2 Diabetes: The Buffering Efficiency Hypothesis. Diabetes Care, 34, S335-S341.
[29] Grizzanti, J.N. and Knapp, A. (1981) Diabetic Ketoacidosis and Invasive Aspergillosis. Lung, 159, 43-49.
[30] Stevens, D.A. and Melikian, G.L. (2011) Aspergillosis in the “Nonimmunocompromised” Host. Immunological Investigations, 40, 751-766.
[31] Kappe, R. and Rimek, D. (2010) Mycoserology—Did We Move on? Aspergillus. Mycoses, 53, 26-29.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.